New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
The FDA announced the discontinuation of Allergan’s Byvalson (nebivolol/valsartan) tablets.
Download PDF
Return to publications
